Entry |
|
Symbol |
PIK3CB
|
Name |
(RefSeq) phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1
|
KO |
K00922 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153] |
|
Organism |
aml Ailuropoda melanoleuca (giant panda)
|
Pathway |
aml01521 | EGFR tyrosine kinase inhibitor resistance |
aml04070 | Phosphatidylinositol signaling system |
aml04072 | Phospholipase D signaling pathway |
aml04213 | Longevity regulating pathway - multiple species |
aml04550 | Signaling pathways regulating pluripotency of stem cells |
aml04613 | Neutrophil extracellular trap formation |
aml04620 | Toll-like receptor signaling pathway |
aml04625 | C-type lectin receptor signaling pathway |
aml04650 | Natural killer cell mediated cytotoxicity |
aml04660 | T cell receptor signaling pathway |
aml04662 | B cell receptor signaling pathway |
aml04664 | Fc epsilon RI signaling pathway |
aml04666 | Fc gamma R-mediated phagocytosis |
aml04670 | Leukocyte transendothelial migration |
aml04750 | Inflammatory mediator regulation of TRP channels |
aml04810 | Regulation of actin cytoskeleton |
aml04914 | Progesterone-mediated oocyte maturation |
aml04919 | Thyroid hormone signaling pathway |
aml04923 | Regulation of lipolysis in adipocytes |
aml04932 | Non-alcoholic fatty liver disease |
aml04933 | AGE-RAGE signaling pathway in diabetic complications |
aml04935 | Growth hormone synthesis, secretion and action |
aml04960 | Aldosterone-regulated sodium reabsorption |
aml04973 | Carbohydrate digestion and absorption |
aml05100 | Bacterial invasion of epithelial cells |
aml05163 | Human cytomegalovirus infection |
aml05166 | Human T-cell leukemia virus 1 infection |
aml05167 | Kaposi sarcoma-associated herpesvirus infection |
aml05168 | Herpes simplex virus 1 infection |
aml05170 | Human immunodeficiency virus 1 infection |
aml05207 | Chemical carcinogenesis - receptor activation |
aml05208 | Chemical carcinogenesis - reactive oxygen species |
aml05230 | Central carbon metabolism in cancer |
aml05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
aml05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:aml00001]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
100463775 (PIK3CB)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
100463775 (PIK3CB)
04014 Ras signaling pathway
100463775 (PIK3CB)
04015 Rap1 signaling pathway
100463775 (PIK3CB)
04370 VEGF signaling pathway
100463775 (PIK3CB)
04630 JAK-STAT signaling pathway
100463775 (PIK3CB)
04668 TNF signaling pathway
100463775 (PIK3CB)
04066 HIF-1 signaling pathway
100463775 (PIK3CB)
04068 FoxO signaling pathway
100463775 (PIK3CB)
04070 Phosphatidylinositol signaling system
100463775 (PIK3CB)
04072 Phospholipase D signaling pathway
100463775 (PIK3CB)
04071 Sphingolipid signaling pathway
100463775 (PIK3CB)
04024 cAMP signaling pathway
100463775 (PIK3CB)
04151 PI3K-Akt signaling pathway
100463775 (PIK3CB)
04152 AMPK signaling pathway
100463775 (PIK3CB)
04150 mTOR signaling pathway
100463775 (PIK3CB)
09133 Signaling molecules and interaction
04081 Hormone signaling
100463775 (PIK3CB)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
100463775 (PIK3CB)
09143 Cell growth and death
04210 Apoptosis
100463775 (PIK3CB)
04218 Cellular senescence
100463775 (PIK3CB)
09144 Cellular community - eukaryotes
04510 Focal adhesion
100463775 (PIK3CB)
04550 Signaling pathways regulating pluripotency of stem cells
100463775 (PIK3CB)
09142 Cell motility
04810 Regulation of actin cytoskeleton
100463775 (PIK3CB)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
100463775 (PIK3CB)
04613 Neutrophil extracellular trap formation
100463775 (PIK3CB)
04620 Toll-like receptor signaling pathway
100463775 (PIK3CB)
04625 C-type lectin receptor signaling pathway
100463775 (PIK3CB)
04650 Natural killer cell mediated cytotoxicity
100463775 (PIK3CB)
04660 T cell receptor signaling pathway
100463775 (PIK3CB)
04662 B cell receptor signaling pathway
100463775 (PIK3CB)
04664 Fc epsilon RI signaling pathway
100463775 (PIK3CB)
04666 Fc gamma R-mediated phagocytosis
100463775 (PIK3CB)
04670 Leukocyte transendothelial migration
100463775 (PIK3CB)
04062 Chemokine signaling pathway
100463775 (PIK3CB)
09152 Endocrine system
04910 Insulin signaling pathway
100463775 (PIK3CB)
04923 Regulation of lipolysis in adipocytes
100463775 (PIK3CB)
04929 GnRH secretion
100463775 (PIK3CB)
04915 Estrogen signaling pathway
100463775 (PIK3CB)
04914 Progesterone-mediated oocyte maturation
100463775 (PIK3CB)
04917 Prolactin signaling pathway
100463775 (PIK3CB)
04926 Relaxin signaling pathway
100463775 (PIK3CB)
04935 Growth hormone synthesis, secretion and action
100463775 (PIK3CB)
04919 Thyroid hormone signaling pathway
100463775 (PIK3CB)
09154 Digestive system
04973 Carbohydrate digestion and absorption
100463775 (PIK3CB)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100463775 (PIK3CB)
09156 Nervous system
04725 Cholinergic synapse
100463775 (PIK3CB)
04722 Neurotrophin signaling pathway
100463775 (PIK3CB)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100463775 (PIK3CB)
09158 Development and regeneration
04360 Axon guidance
100463775 (PIK3CB)
04380 Osteoclast differentiation
100463775 (PIK3CB)
09149 Aging
04211 Longevity regulating pathway
100463775 (PIK3CB)
04213 Longevity regulating pathway - multiple species
100463775 (PIK3CB)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100463775 (PIK3CB)
05206 MicroRNAs in cancer
100463775 (PIK3CB)
05205 Proteoglycans in cancer
100463775 (PIK3CB)
05207 Chemical carcinogenesis - receptor activation
100463775 (PIK3CB)
05208 Chemical carcinogenesis - reactive oxygen species
100463775 (PIK3CB)
05203 Viral carcinogenesis
100463775 (PIK3CB)
05230 Central carbon metabolism in cancer
100463775 (PIK3CB)
05231 Choline metabolism in cancer
100463775 (PIK3CB)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100463775 (PIK3CB)
09162 Cancer: specific types
05210 Colorectal cancer
100463775 (PIK3CB)
05212 Pancreatic cancer
100463775 (PIK3CB)
05225 Hepatocellular carcinoma
100463775 (PIK3CB)
05226 Gastric cancer
100463775 (PIK3CB)
05214 Glioma
100463775 (PIK3CB)
05221 Acute myeloid leukemia
100463775 (PIK3CB)
05220 Chronic myeloid leukemia
100463775 (PIK3CB)
05218 Melanoma
100463775 (PIK3CB)
05211 Renal cell carcinoma
100463775 (PIK3CB)
05215 Prostate cancer
100463775 (PIK3CB)
05213 Endometrial cancer
100463775 (PIK3CB)
05224 Breast cancer
100463775 (PIK3CB)
05222 Small cell lung cancer
100463775 (PIK3CB)
05223 Non-small cell lung cancer
100463775 (PIK3CB)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100463775 (PIK3CB)
05170 Human immunodeficiency virus 1 infection
100463775 (PIK3CB)
05161 Hepatitis B
100463775 (PIK3CB)
05160 Hepatitis C
100463775 (PIK3CB)
05171 Coronavirus disease - COVID-19
100463775 (PIK3CB)
05164 Influenza A
100463775 (PIK3CB)
05162 Measles
100463775 (PIK3CB)
05168 Herpes simplex virus 1 infection
100463775 (PIK3CB)
05163 Human cytomegalovirus infection
100463775 (PIK3CB)
05167 Kaposi sarcoma-associated herpesvirus infection
100463775 (PIK3CB)
05169 Epstein-Barr virus infection
100463775 (PIK3CB)
05165 Human papillomavirus infection
100463775 (PIK3CB)
09171 Infectious disease: bacterial
05132 Salmonella infection
100463775 (PIK3CB)
05135 Yersinia infection
100463775 (PIK3CB)
05100 Bacterial invasion of epithelial cells
100463775 (PIK3CB)
09174 Infectious disease: parasitic
05146 Amoebiasis
100463775 (PIK3CB)
05142 Chagas disease
100463775 (PIK3CB)
09164 Neurodegenerative disease
05010 Alzheimer disease
100463775 (PIK3CB)
05017 Spinocerebellar ataxia
100463775 (PIK3CB)
05020 Prion disease
100463775 (PIK3CB)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100463775 (PIK3CB)
05418 Fluid shear stress and atherosclerosis
100463775 (PIK3CB)
05415 Diabetic cardiomyopathy
100463775 (PIK3CB)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
100463775 (PIK3CB)
04932 Non-alcoholic fatty liver disease
100463775 (PIK3CB)
04931 Insulin resistance
100463775 (PIK3CB)
04933 AGE-RAGE signaling pathway in diabetic complications
100463775 (PIK3CB)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100463775 (PIK3CB)
01524 Platinum drug resistance
100463775 (PIK3CB)
01522 Endocrine resistance
100463775 (PIK3CB)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:aml04131]
100463775 (PIK3CB)
Enzymes [BR:aml01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.1 Phosphotransferases with an alcohol group as acceptor
2.7.1.153 phosphatidylinositol-4,5-bisphosphate 3-kinase
100463775 (PIK3CB)
Membrane trafficking [BR:aml04131]
Endocytosis
Rab GTPases and associated proteins
Rab associated proteins
100463775 (PIK3CB)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
6:10139129..10219712
|
AA seq |
797 aa
MNRTLPHFMLVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKMRIISHVWENNNPF
QIVLVKGNKLNTEESVKVHVRAGLFHGTELLCKTIVSSEISGKNDHIWNEPLEFDINTCD
LPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKSGKVHYPVAWVNTMVFDFKGQLR
SGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHIKFPETKKQPYYYPPFDKIIE
KAAEIASSDSANVSSRGGKKFLAVLKEILDRDPLSQLCENEMDLIWTLRQDCRENFPQSL
PKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDE
ELSQYLLQLVQVLKYEPFLDCALSRFLLERALANRRIGQFLFWHLRSEVHIPAVSVQFGV
ILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAMKLNRAKGKEAMHTCLKQNAYRE
ALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQD
MLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAA
AAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQL
FHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLIL
RRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESW
TTKVNWMAHTVRKDYRS |
NT seq |
2394 nt +upstreamnt +downstreamnt
atgaacaggaccttgccccattttatgcttgtggaatgttgcaagatcaagaagatgtat
gaacaggaaatgattgccatagaggctgccataaatcgaaattcatcaaaccttcctctt
cctttaccaccaaagaaaatgcgaattatttctcatgtttgggaaaataacaaccctttc
caaattgtgttggttaagggaaataaacttaacacagaagaaagtgtaaaagttcatgtc
agggctggcctttttcatggtactgaactcctctgtaaaaccatcgtaagctcagagata
tcagggaaaaatgatcacatttggaatgaaccactggaatttgatataaatacttgtgac
ctgccacgaatggctcgattatgttttgctgtttatgcagttttggataaagtgaaaacg
aaaaagtcgactaaaactattaatccctctaaatatcagaccatccggaaatctgggaaa
gtgcattatcctgtagcatgggtaaatacgatggtttttgactttaaaggacagttgaga
tccggagacataatattgcacagctggtcttcatttcctgatgaacttgaagaaatgttg
aatccaatgggaactgttcaaacaaatccatatactgaaaatgcaacagctttgcatatc
aaattcccagagactaaaaaacaaccttactattatcctcccttcgataagataatcgag
aaggcagctgagattgcaagcagtgacagtgctaatgtatccagtcgaggtggaaaaaag
tttcttgctgtactgaaagaaatcttggacagggatcccttgtctcagttgtgtgagaat
gaaatggatcttatttggactttgcgacaagattgcagagagaatttcccacagtcactg
ccaaaattactgctgtcaatcaagtggaataaacttgaggatgttgctcagcttcaggca
ctacttcagatttggcctaaactgcccccccgggaggccttagagcttctagatttcaac
tatccagatcagtacgtgcgagaatatgctgtgggctgcctgcgacagatgagtgatgaa
gaactctctcaatatcttttacaactggtgcaagttttaaaatatgagccttttcttgat
tgtgccctctctagattcctattagaaagagcactggctaatcggaggatagggcaattt
ctattttggcaccttaggtcagaagtgcatattcctgctgtctcagtacagtttggtgtc
atccttgaagcatactgccggggaagtgtagggcacatgaaagtgctttctaagcaggtt
gaagcactcaataagttaaaaactttaaatagtttaatcaaactgaatgcaatgaagcta
aacagagccaaagggaaggaggccatgcatacttgtttaaaacagaacgcttaccgggaa
gccctctctgacctgcagtcgcctctgaatccatgtgttatcctctcagaactctatgtt
gaaaagtgtaaatacatggattccaaaatgaagcctttgtggctcgtgtacaataacaaa
gtgttcggtgaggattcagttggagtgatttttaaaaatggtgatgatttacgacaagat
atgttgacactccaaatgctgcgcttgatggatttactttggaaagaagctggtctggat
cttcggatgctgccttatggctgtttagcaacaggagaccgctctggcctcattgaagtt
gtgagcacctctgaaacaattgctgacattcagctgaacagtagcaacgtggctgctgca
gcagccttcaacaaagatgcccttctgaactggcttaaagaatacaattctggggatgac
ctagaccgagccattgaggagtttaccttgtcctgtgccggctactgtgtagcttcttat
gtccttgggattggtgatagacatagtgacaacatcatggtcaaaaaaaccggccagctc
ttccacattgactttggacatattcttggaaatttcaagtctaaatttggcattaaaagg
gaacgggtgccttttattcttacctatgatttcattcatgtgattcaacaaggaaaaaca
ggaaacacagagaagtttggccgcttccgccagtgttgtgaggatgcatatctgattcta
cgacggcacgggaatctcttcatcactctttttgcactgatgctgactgcagggcttcct
gagctcacatcagtcaaggatatacagtatcttaaggactctcttgccttagggaagagt
gaagaagaagcactcaagcagtttaagcaaaaatttgatgaggcactcagggaaagctgg
actactaaagtaaactggatggcccacacagttcggaaagactacagatcttaa |